• Amgen Ovarian Cancer Drug Meets Goal of Late-Stage Study
  • Gilead’s Viread Reduces HIV Risk for Drug Users in Study
  • The Top Ten Stocks for Wednesday, June 12
  • Swiss Stocks Are Little Changed After Yesterday’s Drop
  • Human Genome Project Spurred $966 Billion Sciences Boom
« Previous 1 2 Next »